In vivo swine studies have successfully demonstrated the ability to safely treat and precisely destroy brain tissue of spherical and irregular shapes greater than 3 cm.
•
In vivo canine studies have successfully demononstrated the ability to precisely destroy brain tumors without damage to surrounding normal brain tissue.
•
The first human clinical trial is planned in late 2007 with patients having advanced glioblastoma multiforme brain tumors.
*The AutoLITT™ System is an investigational device
which has not yet been tested in humans.